Your donation directly funds research and development for a treatment for dystroglycanopathy caused by a mutation in the B3GALNT2 gene. While our primary focus is this specific mutation, the breakthroughs we achieve in our research willhave broader applications for other types of Congenital Muscular Dystrophy (CMD) subtypes.
Yes. Fight CMD is a 501(c)(3) nonprofit organization. Your contributions are tax-deductible to the fullest extent allowed by law. After completing your donation, you will receive an email receipt for your records.
We are currently making significant strides in the laboratory. Your support helps fund critical research necessary to move a successful treatment toward clinical trials. While our primary focus is on B3GALNT2-related dystroglycanopathy, every discovery brings us closer to a viable treatment and advances clinical trial development for the CMD community.